Thrombosis diagnostic evaluation: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
'''Associate Editors-in-Chief:''' [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org] | '''Associate Editors-in-Chief:''' [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org] | ||
==Overview== | |||
==Diagnostic evaluation== | ===Diagnostic evaluation=== | ||
'''cDNA-PCR assays for gene mutations and polymorphisms:''' | '''cDNA-PCR assays for gene mutations and polymorphisms:''' | ||
:*4G/5G [[polymorphism]] of the [[plasminogen activator inhibitor]]-1 gene (PAI-1) | :*4G/5G [[polymorphism]] of the [[plasminogen activator inhibitor]]-1 gene (PAI-1) | ||
Revision as of 19:16, 12 September 2011
|
Thrombosis Microchapters |
|
Site of Thrombosis |
|---|
|
Differentiating Thrombosis from other Diseases |
|
Diagnosis |
|
Treatment |
|
Thrombosis diagnostic evaluation On the Web |
|
Risk calculators and risk factors for Thrombosis diagnostic evaluation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]
Overview
Diagnostic evaluation
cDNA-PCR assays for gene mutations and polymorphisms:
- 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene (PAI-1)
- Cystathionine beta synthetase (CBS) CBS T833C & G919A
- Factor V Leiden
- Glycoprotein IIIa A1/A2 (platelet glycoprotein)
- Methylenetetrahydrofolate reductase (MTHFR) MTHFR C677T
- Prothrombin G20210A
Serologic (blood) tests:
- Anticardiolipin antibodies (ACLA) IgG and IgM ACLA
- Antithrombin III
- Factor VIII
- Homocysteine
- Lupus anticoagulant (LA)
- Proteins C
- Protein S
Evaluation of hypofibrinolysis
- 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene (PAI-1)(requires cDNA-PCR assay for gene mutation)
- Lipoprotein a Lp(a)
cs:Trombóza de:Thrombose eo:Trombozo it:Trombosi he:תרומבוס ms:Trombotik nl:Trombose fi:Verihiutale